Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 38 | $1,705,457 |
Sells | 2 | $2,168,898 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
12 Dec 2022 16:22 | AVTX | Avalo Therapeutics Inc | NEIL GARRY ARTHUR | CEO and Chairman of the Board | 09 Dec 2022 | Purchase | 2,083 | 4.42 | 9,207 | D |
09 Feb 2023 16:32 | AVTX | Avalo Therapeutics Inc | ARMISTICE CAPITAL, LLC | 10% | 07 Feb 2023 | Purchase | 450,000 | 0 | 0 | I |
11 Apr 2023 16:51 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 11 Apr 2023 | Purchase | 25,000 | 2.8432 | 71,080 | I |
11 Apr 2023 16:51 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 10 Apr 2023 | Purchase | 31,329 | 2.2802 | 71,436 | I |
18 Apr 2023 16:08 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 18 Apr 2023 | Purchase | 10,000 | 2.9438 | 29,438 | I |
18 Apr 2023 16:08 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 17 Apr 2023 | Purchase | 15,000 | 2.9624 | 44,436 | I |
24 Apr 2023 16:32 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 24 Apr 2023 | Purchase | 12,500 | 3.0624 | 38,280 | I |
24 Apr 2023 16:32 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 20 Apr 2023 | Purchase | 5,000 | 3.0783 | 15,392 | I |
27 Apr 2023 16:07 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 27 Apr 2023 | Purchase | 1,504 | 2.96 | 4,452 | I |
27 Apr 2023 16:07 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 26 Apr 2023 | Purchase | 425 | 2.97 | 1,262 | I |
27 Apr 2023 16:07 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 25 Apr 2023 | Purchase | 5,571 | 2.9993 | 16,709 | I |
08 May 2023 16:10 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 08 May 2023 | Purchase | 5,000 | 2.6216 | 13,108 | I |
08 May 2023 16:10 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 05 May 2023 | Purchase | 5,000 | 2.875 | 14,375 | I |
08 May 2023 16:10 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 04 May 2023 | Purchase | 15,000 | 2.7921 | 41,882 | I |
16 May 2023 17:23 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 15 May 2023 | Purchase | 1,715 | 2.5459 | 4,366 | I |
16 May 2023 17:23 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 16 May 2023 | Purchase | 379 | 2.75 | 1,042 | I |
16 May 2023 17:23 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 12 May 2023 | Purchase | 2,285 | 2.45 | 5,598 | I |
22 May 2023 16:30 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 22 May 2023 | Purchase | 7,000 | 3.3368 | 23,358 | I |
22 May 2023 16:30 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 19 May 2023 | Purchase | 6,500 | 3.5157 | 22,852 | I |
22 May 2023 16:30 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 18 May 2023 | Purchase | 13,121 | 3.2896 | 43,163 | I |
24 May 2023 16:15 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 24 May 2023 | Purchase | 5,519 | 2.9622 | 16,348 | I |
24 May 2023 16:15 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 24 May 2023 | Purchase | 3,481 | 3.0072 | 10,468 | I |
30 May 2023 16:27 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 30 May 2023 | Purchase | 671 | 2.867 | 1,924 | I |
30 May 2023 16:27 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 25 May 2023 | Purchase | 2,000 | 2.77 | 5,540 | I |
02 Jun 2023 16:22 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 31 May 2023 | Purchase | 844 | 2.87 | 2,422 | I |
09 Jun 2023 16:24 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 09 Jun 2023 | Purchase | 5,044 | 4.1427 | 20,896 | I |
09 Jun 2023 16:24 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 08 Jun 2023 | Purchase | 6,398 | 3.9271 | 25,126 | I |
09 Jun 2023 16:24 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 07 Jun 2023 | Purchase | 2,984 | 3.4914 | 10,418 | I |
13 Jun 2023 16:39 | AVTX | Avalo Therapeutics Inc | NEIL GARRY ARTHUR | CEO and Chairman of the Board | 09 Jun 2023 | Purchase | 4,000 | 3.42 | 13,680 | D |
13 Jun 2023 16:41 | AVTX | Avalo Therapeutics Inc | SULLIVAN CHRISTOPHER RYAN | Chief Financial Officer | 09 Jun 2023 | Purchase | 511 | 3.42 | 1,748 | D |
14 Jun 2023 16:14 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 14 Jun 2023 | Purchase | 6,000 | 3.479 | 20,874 | I |
14 Jun 2023 16:14 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 13 Jun 2023 | Purchase | 8,750 | 3.8216 | 33,439 | I |
14 Jun 2023 16:14 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 12 Jun 2023 | Purchase | 2,149 | 4.3352 | 9,316 | I |
20 Jun 2023 16:04 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 20 Jun 2023 | Purchase | 2,000 | 4.1444 | 8,289 | I |
20 Jun 2023 16:04 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 16 Jun 2023 | Purchase | 3,000 | 3.9048 | 11,714 | I |
20 Jun 2023 16:04 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 15 Jun 2023 | Purchase | 3,160 | 3.6837 | 11,640 | I |
27 Jun 2023 16:10 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 26 Jun 2023 | Purchase | 182,300 | 0.62 | 113,026 | D |
27 Jun 2023 16:10 | AVTX | Avalo Therapeutics Inc | CAISSA CAPITAL MANAGEMENT LTD. | 10% | 26 Jun 2023 | Purchase | 1,425,700 | 0.6433 | 917,153 | I |
28 Jun 2023 18:12 | AVTX | Avalo Therapeutics Inc | ARMISTICE CAPITAL, LLC | 10% | 27 Jun 2023 | Sale | 937,404 | 0.5194 | 486,888 | I |
28 Jun 2023 18:12 | AVTX | Avalo Therapeutics Inc | ARMISTICE CAPITAL, LLC | 10% | 26 Jun 2023 | Sale | 2,746,138 | 0.6125 | 1,682,010 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)